About
Developer of a minimally invasive, implant-free procedure (excimer laser trabeculostomy) to reduce intraocular pressure. CE-marked in the EU, pursuing FDA. Outcome Capital case-study exit to Bausch + Lomb.
HQ: (EU/Israel)
Funding
Acquired by Bausch + Lomb (2024)
—